|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School, Kurashiki City, Okayama, Japan.
Correspondence to: Naoyuki Miyashita, MD, PhD, Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan; e-mail: nao{at}med.kawasaki-m.ac.jp
Study objective: To investigate the prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults.
Design: Prospective study.
Setting: Kawasaki Medical School Hospital in Kurashiki, Japan.
Participants: Total of 1,018 asymptomatic healthy adults (age range, 22 to 50 years; mean age, 32.4 years; 482 men and 536 women).
Measurements and
results: Nasopharyngeal swab specimens were obtained from all
subjects and analyzed by isolation in cell cultures and polymerase
chain reaction (PCR) test for C pneumoniae. Serum
samples were also obtained and tested for C
pneumoniae-specific antibodies by the microimmunofluorescence
test. Of 1,018 specimens tested, 14 specimens (1.4%) were judged
positive by culture and/or the PCR. Thirteen specimens were PCR
positive, and 4 specimens were culture positive. There were three
specimens positive by both tests and 11 specimens positive with
discrepancies in culture and PCR results. None of the individuals met
the serologic criteria for acute infection. Of 1,018 sera tested,
64.1% of men and 58.0% of women had antibody to C
pneumoniae. The overall prevalence of antibody was 60.9%.
Forty individuals (3.9%) had an IgG titer of
1:512 or IgM titer of
1:16.
Conclusions: Our data suggest that asymptomatic infection with C pneumoniae may occur in subjectively healthy adults.
Key Words: asymptomatic infection Chlamydia pneumoniae healthy adults persistent infection
This article has been cited by other articles:
![]() |
N Teig, A Anders, C Schmidt, C Rieger, and S Gatermann Chlamydophilapneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases Thorax, November 1, 2005; 60(11): 962 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miyashita, H. Fukano, K. Yoshida, Y. Niki, and T. Matsushima Chlamydia pneumoniae infection in adult patients with persistent cough J. Med. Microbiol., March 1, 2003; 52(3): 265 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miyashita, H. Fukano, N. Okimoto, H. Hara, K. Yoshida, Y. Niki, and T. Matsushima Clinical Presentation of Community-Acquired Chlamydia pneumoniae Pneumonia in Adults* Chest, June 1, 2002; 121(6): 1776 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hermann, K. Graf, A. Groh, E. Straube, and T. Hartung Comparison of Eleven Commercial Tests for Chlamydia pneumoniae-Specific Immunoglobulin G in Asymptomatic Healthy Individuals J. Clin. Microbiol., May 1, 2002; 40(5): 1603 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Ben-Yaakov, G Eshel, L Zaksonski, Z Lazarovich, and I Boldur Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection J. Clin. Pathol., May 1, 2002; 55(5): 355 - 358. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |